Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
Explore linked clinical trials.137 results · Page 1 of 6
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant PD-1 Blockade in Patients With Stage IIB/C Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2026-10-09 | NCT03757689 | |
| Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Recruiting | Not applicable | 2026-10-08 | NCT06770855 | |
| CapTemY90 for Grade 2/3 NET Liver Metastases | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-10-08 | NCT04339036 | |
| Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma | Colorectal Adenocarcinoma Metastatic in the Liver | Recruiting | Phase 2 | 2026-10-05 | NCT07082439 | |
| Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Not applicable | 2026-10-05 | NCT07048496 | |
| Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, radiation injury, respiratory system disorder, respiratory tract neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-10-05 | NCT06332131 | |
| Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors | Arrhythmias, Cardiac, B-cell chronic lymphocytic leukemia, Cardiotoxicity, Chemically-Induced Disorders, Chronic Disease, Disease Attributes, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, hematologic disorder, hypertensive disorder, immune system disorder, immunoproliferative disorder, injury, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, radiation injury, vascular disorder | Enrolling by invitation | Not stated | 2026-10-05 | NCT06211413 | |
| Limited-duration Teclistamab | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell myeloma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-10-05 | NCT05932680 | |
| Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Not applicable | 2026-10-05 | NCT05693649 | |
| Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, radiation injury, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2026-10-05 | NCT04305613 | |
| Autoimmunity After Checkpoint Blockade | autoimmune disease, cancer, immune system disorder, neoplasm | Recruiting | Not stated | 2026-10-05 | NCT04119713 | |
| Ovarian Tissue Transplantation | Infertile Females or Females With Ovarian Insufficiency | Recruiting | Not applicable | 2026-10-05 | NCT01870752 | |
| Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy | Pancreatic Adenocarcinoma Metastatic | Recruiting | Phase 2 | 2026-10-02 | NCT06747845 | |
| Penn Medicine Biobank Return of Results Program | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cancer, cardiovascular disorder, hereditary disease, neoplasm | Active, not recruiting | Not applicable | 2026-10-02 | NCT06089954 | |
| Assessment of Geriatric Evaluations Impact on New AML Guidance | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-10-02 | NCT05909501 | |
| Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70) | Advanced Cancer; Geriatric Assessment; Toxicity | Active, not recruiting | Not stated | 2026-09-24 | NCT06870617 | |
| Communication Strategies to Increase HPV Vaccinations | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-09-24 | NCT06784960 | |
| Saruparib in HRDsig+ Solid Tumors | neoplasm | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07832630 | |
| Low Dose Radiotherapy for Osteoarthritis | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, rheumatic disorder | Recruiting | Not applicable | 2026-09-21 | NCT07715188 | |
| Zr89 + PET Companion Trial | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Early phase 1 | 2026-09-21 | NCT05279027 | |
| PROton Therapy for Post Surgical Treatment of GYNecologic Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine cancer, uterine disorder | Recruiting | Phase 2 | 2026-09-17 | NCT05758688 | |
| Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis | Adenomatous Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, adenoma, classic familial adenomatous polyposis, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, neoplasm, polyp | Enrolling by invitation | Not applicable | 2026-09-16 | NCT06578637 | |
| CAR-T Followed by Bispecific Antibodies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, large B-cell lymphoma, lymphatic system disorder, malignant histiocytosis, neoplasm | Active, not recruiting | Phase 2 | 2026-09-14 | NCT04889716 | |
| Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain glioblastoma, epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Early phase 1 | 2026-09-09 | NCT06613841 | |
| DNP-MRSI of HCC Metabolism to Predict Therapeutic Response | Barcelona Clinic Liver Cancer (BCLC) Stage A, B or C HCC | Not yet recruiting | Not stated | 2026-09-08 | NCT07807475 |